Latest News
Vaxcyte (NASDAQ:PCVX) said its investigational 31-valent pneumococcal conjugate vaccine, VAX-31, met all pre-specified primary immunogenicity endpoints in the pivotal Phase III OPUS-1 trial in adults.
The randomized, double-blind, active-controlled study enrolled 4,047 U.S. adults, including 3,572
Via MarketBeat · October 5, 2026
Both companies burn cash heavily while chasing commercialization, but their business models and risk profiles diverge sharply.
Via The Motley Fool · October 5, 2026
Via MarketBeat · October 5, 2026

(Photo: Game Play Entertainment Fun Relax Leisure Graphic | Shutterstock)Digital products compete for more than downloads or sign-ups. They also compete fo
Via Talk Markets · October 5, 2026
Nvidia's 55.6% net margin and $96.7B free cash flow dwarf Taiwan Semi's, but geopolitical risks and customer concentration pose distinct threats to each.
Via The Motley Fool · October 5, 2026
Pedevco (NYSEAMERICAN:PED) outlined plans to accelerate development across its Rocky Mountain oil and gas portfolio while pursuing selective acquisitions, as Interim President, Chief Executive Officer and Chief Operating Officer R.T. Dukes said the company has strengthened its balance sheet and is p
Via MarketBeat · October 5, 2026
Evolution Petroleum (NYSEAMERICAN:EPM) said its strategy remains centered on generating cash flow to support shareholder dividends, while expanding its portfolio of non-operated working interests and mineral and royalty interests across several U.S. producing basins.
Speaking at the Noble Capital M
Via MarketBeat · October 5, 2026
Sandisk is primed to skyrocket over the next few years.
Via The Motley Fool · October 5, 2026
I've curated the best opportunities in my purview.
Via The Motley Fool · October 5, 2026
Cash flow from EV sales funds investment in driverless-car technology and robots.
Via The Motley Fool · October 5, 2026
There is one big difference between these two cybersecurity companies right now.
Via The Motley Fool · October 5, 2026
Cybersecurity stocks have been some of the best performers this year.
Via The Motley Fool · October 5, 2026
Home Depot's sales growth has been below trend for several years in a row.
Via The Motley Fool · October 5, 2026
Soaring revenue, profits, and cash flow, with a stagnating stock price.
Via The Motley Fool · October 5, 2026
The risks from circular financing are increasing in the AI industry.
Via The Motley Fool · October 5, 2026
Higher interest rates have been bad news for stocks in general.
Via The Motley Fool · October 5, 2026
Disney's stock has been falling sharply over the past five years, but investors shouldn't assume it's bottomed out.
Via The Motley Fool · October 5, 2026
The average retiree gets $2,071 monthly, but beating that benchmark doesn't guarantee a secure retirement.
Via The Motley Fool · October 5, 2026
If TSMC joins Musk's chip venture, what does its only named chip partner stand to lose?
Via The Motley Fool · October 5, 2026
Much of this was due to underwhelming quarterly results.
Via The Motley Fool · October 5, 2026
Vaccine breakthroughs and tech talks drove individual stocks higher, while bond yields hit their highest level since 2002, today, Oct. 5, 2026.
Via The Motley Fool · October 5, 2026
In the last 15 years, this cryptocurrency's price has skyrocketed 1,700,000%.
Via The Motley Fool · October 5, 2026
On Oct. 5, 2026, the iron ore miner surged as investors reacted to political developments in Brazil.
Via The Motley Fool · October 5, 2026
Amazon has tremendous growth opportunities in artificial intelligence that don't appear to be priced into its valuation.
Via The Motley Fool · October 5, 2026
What Happened? Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 9.9% in the afternoon session after EpiSign Inc. and Geneyx ...
Via StockStory · October 5, 2026
